37393274|t|Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson's disease via inhibiting oxidative stress and ferroptosis.
37393274|a|Parkinson's disease (PD) is the second most common neurodegenera-tive disorder after Alzheimer disease accompanied by the death of dopaminergic neurons and brain nigrostriatal mitochondrial damage in the elderly population. The features of the disease include tremor, rigidity, postural instability, and motor retardation. The pathogenesis of Parkinson's disease is complex, and abnormal lipid metabolism resulting in ferroptosis due to the excessive accumulation of free radicals from oxidative stress in the substantia nigra of the brain was thought to be one of the factors causing the disease. Morroniside has been reported to have significant neuroprotective effects, although it has not been studied in PD. Therefore, this study focused on determining the neuroprotective effects of morroniside (25, 50, and 100 mg/kg) on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 30 mg/kg)-induced mice models of PD and explored 1-methyl-4-phenylpyridinium MPP+-induced ferroptosis in PC12 cells. Morroniside restored impaired motor function in the PD mice models while reducing neuronal injury. The activation of nuclear factor erythroid 2-related factor 2/antioxidant response elements (Nrf2/ARE) by morroniside promoted antioxidation, the content of reducing agent glutathione (GSH) increased, and the level of the lipid metabolite malondialdehyde (MDA) decreased. Notably, morroniside inhibited ferroptosis in substantia nigra of the brain and PC12 cells, reduced iron levels, and upregulated the expression of the iron-regulated proteins glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), ferritin heavy chain 1 (FTH-1), and ferroportin (FPN). More importantly, morroniside repaired the mitochondrial damage, restored the mitochondrial respiratory chain, and inhibited the production of reactive oxygen species (ROS). These data indicated that morroniside could activate the Nrf2/ARE signaling pathway to increase the antioxidant capacity, thereby inhibiting abnormal lipid metabolism and protecting dopaminergic neurons from ferroptosis in PD.
37393274	27	38	morroniside	Chemical	MESH:C488401
37393274	72	76	zucc	Chemical	-
37393274	85	104	Parkinson's disease	Disease	MESH:D010300
37393274	141	152	ferroptosis	Disease	
37393274	154	173	Parkinson's disease	Disease	MESH:D010300
37393274	175	177	PD	Disease	MESH:D010300
37393274	205	232	neurodegenera-tive disorder	Disease	MESH:D009358
37393274	239	256	Alzheimer disease	Disease	MESH:D000544
37393274	330	350	mitochondrial damage	Disease	MESH:D028361
37393274	414	420	tremor	Disease	MESH:D014202
37393274	422	430	rigidity	Disease	MESH:D009127
37393274	432	452	postural instability	Disease	MESH:D054972
37393274	458	475	motor retardation	Disease	MESH:D019957
37393274	497	516	Parkinson's disease	Disease	MESH:D010300
37393274	542	547	lipid	Chemical	MESH:D008055
37393274	572	583	ferroptosis	Disease	
37393274	621	634	free radicals	Chemical	MESH:D005609
37393274	752	763	Morroniside	Chemical	MESH:C488401
37393274	863	865	PD	Disease	MESH:D010300
37393274	943	954	morroniside	Chemical	MESH:C488401
37393274	982	1026	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Chemical	MESH:D015632
37393274	1028	1032	MPTP	Chemical	MESH:D015632
37393274	1067	1069	PD	Disease	MESH:D010300
37393274	1083	1115	1-methyl-4-phenylpyridinium MPP+	Chemical	-
37393274	1124	1135	ferroptosis	Disease	
37393274	1139	1143	PC12	CellLine	CVCL:0481
37393274	1151	1162	Morroniside	Chemical	MESH:C488401
37393274	1203	1205	PD	Disease	MESH:D010300
37393274	1233	1248	neuronal injury	Disease	MESH:D009410
37393274	1268	1311	nuclear factor erythroid 2-related factor 2	Gene	18024
37393274	1343	1347	Nrf2	Gene	18024
37393274	1356	1367	morroniside	Chemical	MESH:C488401
37393274	1422	1433	glutathione	Chemical	MESH:D005978
37393274	1435	1438	GSH	Chemical	MESH:D005978
37393274	1472	1477	lipid	Chemical	MESH:D008055
37393274	1489	1504	malondialdehyde	Chemical	MESH:D008315
37393274	1506	1509	MDA	Chemical	MESH:D008315
37393274	1531	1542	morroniside	Chemical	MESH:C488401
37393274	1553	1564	ferroptosis	Disease	
37393274	1602	1606	PC12	CellLine	CVCL:0481
37393274	1622	1626	iron	Chemical	MESH:D007501
37393274	1673	1677	iron	Chemical	MESH:D007501
37393274	1697	1721	glutathione peroxidase 4	Gene	29328
37393274	1723	1727	GPX4	Gene	29328
37393274	1730	1763	solute carrier family 7 member 11	Gene	310392
37393274	1765	1772	SLC7A11	Gene	310392
37393274	1775	1797	ferritin heavy chain 1	Gene	25319
37393274	1799	1804	FTH-1	Gene	25319
37393274	1848	1859	morroniside	Chemical	MESH:C488401
37393274	1873	1893	mitochondrial damage	Disease	MESH:D028361
37393274	1973	1996	reactive oxygen species	Chemical	MESH:D017382
37393274	1998	2001	ROS	Chemical	MESH:D017382
37393274	2030	2041	morroniside	Chemical	MESH:C488401
37393274	2061	2065	Nrf2	Gene	18024
37393274	2154	2159	lipid	Chemical	MESH:D008055
37393274	2212	2223	ferroptosis	Disease	
37393274	2227	2229	PD	Disease	MESH:D010300
37393274	Positive_Correlation	MESH:C488401	18024
37393274	Negative_Correlation	MESH:C488401	MESH:D008315
37393274	Association	MESH:D008055	MESH:D010300
37393274	Association	MESH:D007501	25319
37393274	Positive_Correlation	MESH:C488401	310392
37393274	Association	MESH:D005609	MESH:D008055
37393274	Positive_Correlation	MESH:C488401	29328
37393274	Association	MESH:D007501	310392
37393274	Association	MESH:D007501	29328
37393274	Negative_Correlation	MESH:C488401	MESH:D017382
37393274	Association	MESH:D008055	MESH:D008315
37393274	Negative_Correlation	MESH:C488401	MESH:D010300
37393274	Negative_Correlation	MESH:C488401	MESH:D028361
37393274	Negative_Correlation	MESH:C488401	MESH:D007501
37393274	Positive_Correlation	MESH:C488401	MESH:D005978
37393274	Positive_Correlation	MESH:D015632	MESH:D010300
37393274	Association	MESH:D008055	18024
37393274	Positive_Correlation	MESH:C488401	25319
37393274	Negative_Correlation	MESH:C488401	MESH:D009410
37393274	Negative_Correlation	MESH:C488401	MESH:D008055

